[" 7.3 billion", " Middle East respiratory syndrome", " Model parameters and outbreak control", " January 30, 2020,", " (H7N9)", " Countries have been successful in the past", " 20%", " 20%", " 2.2.9", " 35\u202f000 to 60\u202f000", "\nHMPV", " no approved vaccines or medications available", " influenza virus and RSV infections", " protect against infection across diverse viral isolates", " Dysregulation of the antibody response", " hybridoma", " somatic rearrangement", " diagnostic, therapeutic, and research reagents.", " intensified efforts to understand the developmental pathway", " development of new diagnostic, therapeutic, and research reagents.", " the identification of B cells that target this relatively conserved site", " active role.", " Dysregulation of the antibody response", " 2012,", " 21%", " male", " Dromedary camels", " 11-13 days", " 16 days", " healthcare facilities", " 43.", " pneumonia (59%), followed by bronchitis", " bronchitis, pneumonia and bronchiolitis", " NK cells", " reactive oxygen species", " ROS", " June 30, 2017", " important and evolving threats to the health of the fastgrowing global population.", " lowincome or middle-income country.", " proven leader and advocate, perhaps from a lowincome or middle-income country.", " (parainfluenza virus 4,", " Coronavirus OC43;", " 2-5 times higher than in developed countries", " continent of Africa", " environmental risk factors.", " mild cold-like symptoms", " Coronavirus OC43;", " most common", " 12.5%", " increased severity", " community surveillance", " medical applications", " colorectal cancer", " 83.2%", " 64.3%,", " detection of nuclear condensation.", " apoptotic chromatin changes,", " aberrant cells", " HT-29 cells", " (sixth edition)", " HCQ", " weak base and immunomodulator,", " lack of studies on the impact", "\nClinical investigation", " Wuhan, China", " 34,598", " The steps of the proposed FPASSA", " GA-SSA-ANFIS", " to improve FPA to avoid its drawbacks", " splinting its population into a leader group and followers group.", " GA-SSA-ANFIS", " time series prediction and forecasting problems,", " good performance", " two datasets of weekly influenza confirmed cases", " good performance.", " severe pathogens for human beings,", " humans, birds, livestock, mice, bats, and other wild animals", " time series prediction and forecasting problems,", " flexibility in determining nonlinearity in the time series data,", " time series prediction and forecasting problems,", " ordered weighted averaging", " particle swarm optimization", " artificial neural networks", " multi-verse optimizer", "\nFlower Pollination Algorithm", " individual SI algorithms may stock at local optima.", " ordered weighted averaging", " an improved ANFIS model based on a modified flower pollination algorithm", " flow pollination process of the flowering plants.", " [48]", " formatting the input data in a time series form.", " by receiving the historical COVID-19 dataset.", " a modified version for the flower pollination algorithm", " their available ICU beds,", " highly contagious with multiple transmission route, high exposure dose,", " transferring patients to other institutions, and restricting hospital visitors", " lack of diagnosis kits", " The numbers shown after February 9", " bat beta-coronaviruses,", " 1,000", " severe acute respiratory syndrome", " \u223c80%", " 99.8% homology,", " greater than 1,100 nt", " Given that there are greater than 1,100 nt differences", " The absence of a logical targeted pattern", " construction of a chimeric CoV with a bat CoV S gene", " significant divergence in the genetic sequence", " chimeric virus", " infection was attenuated,", " due to the mouse adaptation.", " unable to use human ACE2 as a receptor for entry into human cells", " several novel bat coronaviruses were isolated from Chinese horseshoe bats", " an intermediate host may not be necessary", " the exact S gene from bat coronavirus SL-SHC014", " elevated replication and lung pathogenesis in aged mice", " elevated pathogenic activity", " significant divergence in the genetic sequence", " HIV sequence in it", " multiple HIV insertions into the SARS-CoV-2", " the authors who made the initial claim have already withdrawn this report.", "\nEvolution is stepwise and accrues mutations gradually over time,", " the authors who made the initial claim have already withdrawn this report.", " the authors who made the initial claim have already withdrawn this report.", " severe acute respiratory syndrome", " 12 December)", " West Africa.", " 2003", " 31 December", " 26 January 2020,", " 4 weeks,", " reverse transcription polymerase chain reaction tests", " 1000", " 10 days.", " rapid and transparent sharing of information between countries and agencies.", " 2014.", " less than 2 weeks", " at least one", " 34%", " volume and diversity of the information available and the relative lack of verification mechanisms,", " autoinfection,", " their families and the communities", " 3", " a case infected significantly more contacts than the average.", " 5 m people", " planning and conducting safe patient transport", " the ability of a given host to tolerate an infection,", " Severe acute respiratory syndrome coronavirus", " Middle East respiratory syndrome", " 2003", " 8000", " 35-50%", " 10%", " double membrane vesicles", " infection with other viruses or bacteria", " rapid progression to ARDS,", " rapid progression", " timing", " double membrane vesicles (DMVs),", " the host transcriptome", " there is a lack of both patient and experimental data.", " double membrane vesicles", " increase the potential benefits", " 21st century", " SARS-CoV uses the ACE2 receptor to gain entry to cells,", " decrease mortality and also length of hospital stays", " increase the potential benefits", " increased pathogen burden, and thus increase virus-induced pathology", " protect against inflammation-induced death", " host to tolerate the effects of pathogens and the immune response to pathogens.", " can lead to future host-based therapies that could increase patient survival", "\nCorticosteroids", " higher neutrophil count and low T-cell counts", " Host resilience", " If host gene responses are maintained this may increase disease resilience.", " These factors can serve as a guide to new potential therapies for improved patient care.", " The systematic review", " 6", " 2%).", " males with a median age of 55 years", " fever, cough, and myalgia or fatigue.", " Novel Coronavirus", " SAR-CoV.", " (SARS-CoV) and Middle East respiratory syndrome coronavirus", " similarly to SAR-CoV.", " similarly to SAR-CoV.", " (PubMed, Embase and Cochrane Library)", " to identify published studies", " diagnosis, therapeutic drugs and vaccines", " SARS and MERS vaccines", " five webpage links from government and international bodies with official information and guidelines", " real time RT-PCR", " play an important role in the diagnosis of 2019-nCoV.", " immunoblot analysis and immunofluorescence assays,", " comparable to the usual diagnostic tests", " based on specific TaqMan probes.", " high levels of PCR inhibition may hinder PCR sensitivity", " molecular test has better sensitivity and specificity.", " nested PCR", " 10 genome equivalents per reaction", " high accuracy.", " synthetic DNA-based", " Clinical trials", " excluded as they were performed in cell or animal models", " Phase I clinical trials on SARS or MERS vaccines", " limit transmission of respiratory infectious diseases.", " safe, well-tolerated", " nine", " clinical trials registry (ClinicalTrials.gov)", " frequent mutations and recombination events.", " only 3% maintained neutralisation activity to end of study.", " 71% and 76% participants after 2 and 3 doses,", " antibody levels, and viral load respectively were similarly inconsistent across available literature.", "\nImproved mortality", " SARS therapeutics", " usage of ribavirin", " positive results,", " research purposes.", " The fast and accurate diagnosis", " detecting the genetic material of the virus,", " adaptive evolution", " the need to collect paired serum samples", " long duration", "\nImproved mortality", " obvious", " have higher and more prolonged levels of viral RNA", " longer viral shedding", " lower viral loads", " real time RT-PCR", " better sensitivity and specificity.", " Germany.", " systematic review (Table 6)", " TaqMan probes.", " All patients recovered.", " to be safe and well-tolerated at single doses.", " Nod-like receptor family, pyrin domain-containing 3", " mitochondrial ROS", " RIPA buffer", " transmembrane pore-forming viral proteins,", " Betacoronavirus", " Coronaviridae,", " enveloped", " single-stranded", " 8,098", " 9.6%,", " tumor necrosis factor", " by sensing the cellular damage or distress induced by viroporins", " 274", " Ca 2+ -permeable", " NLRP3 inflammasome", " 85 years and older.", " easily from person-to-person.", " 50", " March 16,", " avoid cruise travel and non-essential air travel.", " betacoronavirus,", " novel influenza viruses.", " recognition, initiation, and acceleration phases.", " acceleration phase,", " chronic", " rRT-PCR", " bats.", "\nDoes the patient have recent travel from an affected area?", " coronavirus 2", " December 2019", " Wuhan, China.", " daily air travel volume", " February 4, 2020.", " 2012", " Jordan", " Jeddah,", " camel shepherds", " across the Arabian Peninsula and in parts of Africa,", " transfer to the designated isolation treatment facility.", " Droplet spread", " lengthy exposure", " The KSA", " Middle East respiratory syndrome,", " unfamiliarity of local clinicians", " RT-PCR", " Older males", " cross-reactivity", " 68 M;", " slaughterhouse workers", " widespread evidence of past infection in adult camels and limited past exposure among humans.", " An email", " website of the professional emerging diseases", " 20 th September 2012", " Jeddah,", " 1,493", " 20 % to 40 %", " influenza viruses circulated widely,", " lengthy exposure", " restricting close contact or prolonged exposure of infected people to others,", " subject to routine biosafety considerations", " exopeptidase dipeptidyl peptidase 4", " (~3 % prevalence)", " (~3 % prevalence)", " sporadically", " Older males", " outbreaks in hospitals,", " the equivalent of a 'common cold'", " co-detections", " five to six days,", " 13 to 14 days", " 11 to 13 days,", " asymptomatic", " a probable MERS-CoV case", " 79 %", " most pilgrims arrived from MERS-free countries.", " co-infections or alternative viral diagnoses", " pneumonia, or worse, and secondary bacterial infections", " acute respiratory distress syndrome,", " death [94]", " 16 %", " 185 cases and 36 deaths", " PCR-based techniques", " open reading frames", " nucleotide polymorphisms.", " genetic evidence", " 94 % sensitivity", " pre-existing antibody,", " PCR-based techniques", " subgenomic sequencing,", " low transmission rate", " low transmission rate", " confirmatory IFA", " transmission studies.", " four or more weeks", " when sample collection is delayed", " hospitalized cases", " PCR-based techniques", " serological testing", " if collected two weeks after onset of disease", " 12 to 26 days", " long periods", " Over three quarters", " 30 days,", " 30", " tracheal aspirates and BAL", " nasopharyngeal aspirates", " nasopharyngeal aspirates", " bronchoalveolar lavage", " 20 % to 40 %", " 20 % to 40 %", " low transmission rate", " animal MERS-CoV infections", " virus or viral RNA", " seropositive and RNA or virus negative", " winter months", " new infections among na\u00efve DC populations", " asymptomatic", " at least 72 h later", " 48 h [150]", " pasteurization", " 24 h [150]", " 45 min", " 4 m.", " DCs", " \"contact\"", " \"contact\"", " \"contact\"", " \"contact\"", " \"contact\"", " two to three months", " readily transmit to more than one other human", " <1,", " <1,", " ongoing, sporadic spill-over events from DCs", " acute LRT disease", " Jordan.", " 43", " 21", " 16", " validated RT-rtPCR assays", " human-derived MERS-CoV genomes from Jordan,", " blue vertical bars.", " two", " Riyadh", " Riyadh-2014,", " three or four generations", " poor infection control", " 37 cases died [189]", " Global alignment of case definitions", " negative for other pathogens", " evidence is lacking", " direct and within 10 days prior to symptom onset", " timely disinfection", " low-dose screening", " it can help identify the degree of pulmonary\ninvolvement and disease course.", " Fever tents", " 1 mm-thick", " dissemination of up-to-date case definitions", " Dissemination of this information to all healthcare facilities", " understand the\nextent and dynamic evolution of lung lesions induced by COVID-19.", " to scan the patient.", "\ndocuments regarding infection control and CT findings of COVID-19", " four areas:", " WeChat", " the administrative office and the diagnostic room.", " (shaded in dark gray),", "\naccess areas for medical personnel and a dressing area for technologists.", " in accordance with the procedures and under the supervision of\nthe infection control nurse.", " taking time off", " Pregnant staff", " data gathering, collaboration, needs assessment, and expert advice", " the highest level of infection control\nmeasures must be implemented,", " 80,793 confirmed cases and 3,169", " 3,169", " whom13,701", " December 2019", " dry coughing", " real-time PCR in the clinical lab.", " positively correlated", " Patients who were with at least one of the following symptom", " positively correlated", "Detectable 2019-nCoV viral RNA", " positively correlated", " highly suspected infection", " unavailability of convincingly scientific evidence.", " clinical severity", " TGEV accessory gene 7,", " RP transmission model,", " RP model", " Results", " If R 0 < 1, the outbreak will toward an end.", " the Chinese New Year holiday.", " The transmission network of Bats-Host was ignored.", " four compartments:", " Bats-Host", " (the seafood market)", " five compartments:", " 5.2 days", " 5-day", " 3 to 7 days", " (10 days)", " 0.5 times that of symptomatic infection", " 0.3 million", " 2.87 million", " 2.5-7.2", " 2.30 from reservoir to person and 3.58 from person to person", " 0.8-1.3 [31]", " MERS", " decrease R 0", " moving volume of 0.2 million per day", " to provide a mathematical model", " spherical, enveloped, and the largest of positive-strand RNA viruses.", " Bats", " 199", " 2 to 4 February,", " secondary transmissions on board.", " a passenger who started coughing", " 1 February,", " 199", " 5.0 days [3]", " highly successful", " 0.98 persons", " 31 December 2019,", " 63.1 million", " 2.1%", " lack of awareness or recall bias,", " it has direct implications for public health and hospital infection control.", " 10 days after illness onset", " from person to person,", " 2.2,", " 7.5 days [2]", " a slightly lower basic reproductive number.", " Control measures and changes in population behaviour", " 10 days", " more than 75,000", " the day of illness onset", " through large respiratory droplets,", " from person to person,", " indirect transmission via fomites", " Coronaviruses", " faecal-oral,", " through a surveillance system for pneumonia of unknown aetiology,", " there could be many more mild infections than severe infections.", " it determines the strength of public health response required.", " to determine high risk groups.", " older adults, obese individuals or those with underlying medical conditions,", " when not all exacerbation events occurred during the viral infection", " viral infection increases airway inflammation which aggravates disease symptoms.", " PCR technology,", " circulating miRNA changes", " recent findings of viral interaction with the upper airway.", " recent findings of viral interaction with the upper airway.", " potential exacerbation mechanisms and the associated viruses", " synergistic effect of viral infection with other sensitizing agents", " the current", " chronic airway inflammatory diseases", " worldwide.", " complexity and heterogeneity of the disease.", " impaired bacterial immune response,", " high morbidity and even mortality worldwide.", " morbidity and sometimes mortality", " non-classical symptoms of chronic airway inflammatory diseases.", " infiltration of activated immune cells", " viral infection", " Th1 and ILC1 cells", " their ease of transmission and infection", " increase neutrophilic activation;", " to properly manage exacerbations via supplementary treatments", " dysregulated inflammation", " upper airway", " recent findings of viral interaction with the upper airway.", " \"united airway\" hypothesis", " viral infection", " more viruses were recovered during acute exacerbations events", " nasal epithelium", " pathogenic bacteria", " pathogenic bacteria", " they can infect both the upper and/or lower airway,", " within airway epithelial cells", " the cells release antiviral factors and cytokines", " type 1 inflammatory responses", " impaired or aberrant,", " recent findings of viral interaction with the upper airway.", " compiling and collating the current known mechanisms of viral-induced exacerb", " to perpetuate type 2 inflammation when activated", " massive damage and cell death to the epithelial barrier,", " airway remodeling", " prolong airway inflammation", " increased susceptibility to viral infections", " greatly affect the patients' quality of life", " worsens the classical symptoms of disease", " greatly affect the patients' quality of life", " IL-25, IL-33 and TSLP", " ILC2s", " massive damage", " infiltration", " Viral involvement", " do not activate an ILC2 response", " increases airway inflammation", " acute exacerbation", " interplay between virus and pathogenic bacteria", " the nasal epithelium remains the primary site of most infections.", " synergistic effect of viral infection with other sensitizing agents", " impaired or reduced ability of viral clearance", " impaired or reduced ability of viral clearance", " Subsequent analysis of functions may use epithelial cell models", " recent data regarding viral interactions with the airway epithelium", "\nPatients with chronic airway inflammatory diseases", " resistance development", " developed nations", " increase the infiltration rate of eosinophils", " lack of antiviral clearance", " enhance granulocyte infiltration", " human papilloma virus", " chronic airway inflammatory diseases,", " continuous expression of antiviral genes", " cause the virus to linger longer in the airway", " resolve the dual complications arising from viral infection.", " COVID-19 virus)", " increase neutrophilic activation;", " further compounds the cell deaths in IFV infected epithelium", " cell death", " epithelial remodeling", " receive their annual influenza vaccination", " PCR technology,", " increase neutrophilic activation;", " chronic rhinosinusitis,", " biofilm colonies", " the relationship between asthma and COPD exacerbations", " viral respiratory infections,", " increase neutrophilic activation;", " DNA methylation", " impaired bacterial immune response,", " viral respiratory infections,", " their presence may further alter the local environment", " restoring the intestinal microbiome", " increase neutrophilic activation;", " airway epithelial cells", " increase contact between environmental triggers with the lower airway and resident immune cells.", " oxidative stress", " histone modifications", " growth of pathogenic bacteria", " inflammation and alteration of the lower airway environment,", "Respiratory Viral Infections", " promote a Type 2-biased immune response", " disrupt the equilibrium of the mucociliary function following viral infection,", " more foreign material and allergen to enter the airway,", " microbiome-based therapies", " viral infections", " circulating miRNA changes", " viral infections", " increase miR-21 and augmented inflammation in experimental murine asthma models,", " induce oncostatin M (OSM) which causes tight junction opening", " miR-22", " targets to modulate viral induced airway changes", " epigenetic modifications", " the association of epigenetic modification and chronic airway inflammatory diseases,", " exacerbation mechanisms.", " antiviral factors", " an altered inflammatory state", " prolong exacerbation episodes", " oxidative stress", " increase neutrophilic activation;", " infiltrating cells", " increases airway inflammation", " important information regarding viral pathogenesis", " epithelial cell models", " to identify systemic mechanisms of acute exacerbation", " metagenomics", " the best mode of verification of the associations of the virus", " complex interactions between the host and the exacerbation agents,", " interventions implemented several weeks earlier.", " (11th March),", "\n3 days", " (NPIs)", " semi-mechanistic Bayesian hierarchical model", " wide credible intervals", " changes in the\nreproductive number\u2014", " 2-3 weeks", " reducing transmission in countries with more advanced\nepidemics.", "\ninfections will increase", " 23rd January,", " zero new confirmed indigenous cases in Wuhan by\nMarch 19th.", " local and national Iockdowns.", " Daily number of confirmed deaths,", " importation being the dominant source of new infections early\nin the epidemic,", " Sentinel data.", " 9.8%", " 16,000 [5,400-35,000]", " Germany", " 1.1%", "\nBelgium 3.7%", "\nDenmark 1.1%", " 3.0%", " 0.7%", " 9.8% [3.2%-25%]", " 0.41%", " 15%", " 15%", " 3.2%", " 55.", " 50% 753%", " Sweden bans large events to halt coronavirus spread.", "\nThe close spacing of interventions in time", " deaths", "\nFollowing the hierarchy from bottom to top", " (k=5)", "\nunderreporting as well as systematic and country-specific changes in testing.", " (SARS-CoV-Z)", " (Norway/Denmark)", " banning all public events of more than 100 participants such as\nsports events.", " banning large gatherings and advising individuals not to socialize outside\ntheir households),", " banning large gatherings and advising individuals not to socialize outside\ntheir households),", " (k=5)", " (time from infection to the onset\nof symptoms),", " (time from the onset of symptoms to death),", " (1%)", " the initial reproduction number before interventions and the effect sizes from\ninterventions.", " (infection to onset of symptoms", " (infection to onset of symptoms", " between 1.88% and 11.43%", " (infection to onset of symptoms", " (time from infection to the onset\nof symptoms),", " semi-mechanistic.", " COVID-19", " Coronavirus:", " 5.9 [1.9-15.2] million", " through respiratory tract", " through respiratory, fecal-oral or body fluid routes.", " not perfect.", " not perfect.", " patients, indicating serology", " two times of negative detection from oral swabs.", " dyspnea", " pre-existing conditions", " 27 January 2020.", " 27", " Europe;", " 42 years;", " 25", " 4,250", " 12 January 2020,", " coronavirus disease 2019", " UK)", " Data on 38 of these cases", " approval to the final draft.", " to support the global strategy of containment of COVID-19", " inform country preparedness; and improve further case detection and management.", " 27 February 2020", " 15 February", " 14 days [11]", " two reported in Italy and two reported in France,", " Germany and France,", " six", " to isolate the person", " 2 days", " 16", " This was consistent with the epidemiological situation in Asia,", " 31", " Two", " screening following repatriation and during contact tracing", " 20", " 16", " seven", " five", " one had pre-existing cardiac disease.", " 14", " benign", " admitted to intensive care", " hospitalised for 21 days and required intensive care and mechanical ventilation for 19 days.", " The duration of hospitalisation was reported for 16 cases", " gave approval to the final draft.", " two clusters in Germany and France,", " 4,250", " France and Germany.", " 3 days longer", " significant resources for contact tracing and quarantine,", " a history of travel to China.", " repatriation and during contact tracing", " include fever among several clinical signs or symptoms indicative for the suspected case definition.", " to help plan for the impact on the healthcare system and the wider population.", " to understand the proportion of cases who are asymptomatic.", " estimate the incidence of severe cases and identify risk factors for severity and death.", " to help identify evidence of widespread community transmission", " globally", " to ensure early detection of local circulation of COVID-19,", " exponential", " unreported cases from 1 to 15 January 2020.", " basic reproduction number", " 21-fold", " 2.56", " 1 to 15 January 2020.", " mainland China", " fever, cough, and shortness of breath", " 40,", " 2066", " Republic of Korea, Hong Kong, Taiwan, Australia, and the United States,", " the basic reproduction number", " Wuhan Municipal Health Commission", " National Health Commission of China", " through the exponential growth.", " through the exponential growth.", " IFN antagonist activity analysis", " compared it with the genomes of related \u03b2CoVs", " 40%", " 89% nucleotide identity", " More animal sampling", " enveloped, positive-sense, single-stranded RNA viruses", " Alphacoronavirus (\u03b1CoV), Betacoronavirus", " bats and rodents are the gene sources of most \u03b1CoVs", " severe acute respiratory syndrome CoV (SARS-CoV)", " bats", " 6", " self-limiting upper respiratory infections", " may cause severe lower respiratory tract infection", " cases of pneumonia of unknown cause", " orf8 amino acid sequences.", " 2019-nCoV HKU-SZ-005b", " bats and rodents", " MEGA X software,", " Poisson correction method", " PSI-", " bioinformatics.", " HKU-SZ-005b", " 38%.", " closest human pathogenic virus", " orf3b, Spike and orf8", " a signal peptide,", " conserved fusion peptide", " preventive and treatment modality for testing in animal models before clinical trials", " shares around 70% identity", " external subdomain,", " amino acid differences of RBD are located in the external subdomain,", " its receptor usage, interspecies transmission and pathogenesis.", " deletions in the spike receptor binding domain (RBD)", " WIV1", " can use human ACE2 as a cellular entry receptor.", " suckling rats", " The two retained deletion sites in the Spike genes", " different orf3b proteins display different IFN antagonist activities", " an accessory protein found in the Betacoronavirus lineage B coronaviruses.", " fulllength orf8 [23]", " two bat SARS-related-CoV", " bat SARS-related-CoV ZXC21 and ZC45.", " distant", " recombination hot spots.", " to form a protein with an alpha-helix,", " Table 2", " Wuhan, Hubei Province, China;", " (GISAID)", " E and RdRp genes,", " negative progression and adverse outcomes", " 1.4 times more likely", " it is suspected to be transmitted through contact with infected respiratory secretions,", " Washington.", " January 15, 2020,", " January 24, 2020.", " Chicago health authorities", " January 30, 2020,", " January 30, 2020,", " January 31, 2020,", " coughing or difficulty breathing accompanied by fever.", " pneumonia or as a nonspecific lower respiratory illness,", " Healthcare personnel", " between 2 and 14 days,", " through contact with infected respiratory secretions,", " low,", " Over 168 million", " those in complex humanitarian crises,", " Poor governance, public distrust, and political violence", "\nPopulations affected by humanitarian crises", " pandemics", " reduce access to", " limited public health, laboratory, and primary care services", " latrines in crisis settings are often shared and distant from residential shelters,", " Frequent displacement and limited contact information", " overcrowding", " humanitarian crises", " to protect healthcare workers,", " Respiratory hygiene", " Respiratory hygiene", " soap", " the rights to dignity", " alcohol-based hand rubs", "\nThe Sphere Handbook,", " hand hygiene to prevent respiratory pathogen transmission.", " evidence pertaining to the prevention of illnesses", " latrines", " to prevent respiratory pathogen transmission.", " Crisis-affected community engagement", " mitigation plans will fall short of health and human rights obligations", " Transparent and credible information-sharing mechanisms", " Crisis-affected community engagement"]